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Abstract 
Background: In recent years, we have come to recognize that a multitude of in utero exposures have the capac-
ity to induce the development of congenital and metabolic defects. As most of these encounters manifest their 
effects beyond the window of exposure, deciphering the mechanisms of teratogenesis is incredibly difficult. For 
many agents, altered epigenetic programming has become suspect in transmitting the lasting signature of exposure 
leading to dysgenesis. However, while several chemicals can perturb chromatin structure acutely, for many agents 
(particularly alcohol) it remains unclear if these modifications represent transient responses to exposure or heritable 
lesions leading to pathology.
Results: Here, we report that mice encountering an acute exposure to alcohol on gestational Day-7 exhibit signifi-
cant alterations in chromatin structure (histone 3 lysine 9 dimethylation, lysine 9 acetylation, and lysine 27 trimethyla-
tion) at Day-17, and that these changes strongly correlate with the development of craniofacial and central nervous 
system defects. Using a neural cortical stem cell model, we find that the epigenetic changes arising as a consequence 
of alcohol exposure are heavily dependent on the gene under investigation, the dose of alcohol encountered, and 
that the signatures arising acutely differ significantly from those observed after a 4-day recovery period. Importantly, 
the changes observed post-recovery are consistent with those modeled in vivo, and associate with alterations in tran-
scripts encoding multiple homeobox genes directing neurogenesis. Unexpectedly, we do not observe a correlation 
between alcohol-induced changes in chromatin structure and alterations in transcription. Interestingly, the majority 
of epigenetic changes observed occur in marks associated with repressive chromatin structure, and we identify correl-
ative disruptions in transcripts encoding Dnmt1, Eed, Ehmt2 (G9a), EzH2, Kdm1a, Kdm4c, Setdb1, Sod3, Tet1 and Uhrf1.
Conclusions: These observations suggest that the immediate and long-term impacts of alcohol exposure on chro-
matin structure are distinct, and hint at the existence of a possible coordinated epigenetic response to ethanol during 
development. Collectively, our results indicate that alcohol-induced modifications to chromatin structure persist 
beyond the window of exposure, and likely contribute to the development of fetal alcohol syndrome-associated 
congenital abnormalities.
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Background
From studies using a diverse range of model organisms, 
we now acknowledge that epigenetic modifications to 
chromatin structure provide a plausible link between 
environmental exposures and alterations in cellular func-
tion leading to pathology [1]. These revelations create 
novel perspectives in our understanding of fetal develop-
ment that must be investigated if we are to fully under-
stand the molecular origins of birth defects. However, for 
many teratogens the link between exposure and altered 
epigenetic programming remains poorly defined.
Alcohol consumption during pregnancy is widespread 
in our society despite its proven association with the 
development of birth defects and severe mental impair-
ment. Work from a number of independent research 
groups have demonstrated that ethanol (EtOH) has the 
capacity to alter chromatin structure, which suggests that 
epigenetic mechanisms may be relevant to the genesis of 
birth defects associated with fetal alcohol spectrum dis-
orders (FASDs) [2–4]. For example, studies examining 
tissue samples derived from both humans and rodents 
chronically exposed to alcohol have shown alterations 
in the levels of both the DNA methylating enzyme DNA 
methyltransferase 1 (Dnmt1) and DNA methylation 
within the regulatory regions of multiple genes; includ-
ing those regulated though genomic imprinting [5–9]. In 
addition, multiple in  vitro studies have revealed altera-
tions in post-translational histone modifications arising 
as a consequence of ethanol exposure [10–14]. However, 
important questions as to the lasting heritability, the 
mechanism of induction, and the role these epigenetic 
errors have in the development of FASD-associated con-
genital malformations remain to be resolved.
In adults, alcohol is converted to acetaldehyde in an 
oxidation reaction that occurs primarily in the liver, and 
is driven by the enzymes alcohol dehydrogenase (ADH), 
cytochrome P450 (CYP2E1), and catalase. Even under 
normal physiologic conditions, this process produces 
excess acetaldehyde, reactive oxygen species (ROS) and 
other harmful adducts inducing oxidative stress [15]. Due 
to the free passage of alcohol from mother to fetus, and 
the constant recycling of the amniotic fluid reservoir, 
fetal alcohol exposures achieve blood alcohol concentra-
tions equivalent to the mother’s, but of longer durations 
[16–18]. These longer exposures produce significant lev-
els of ROS and free radicals, which have been hypothe-
sized to be a significant factor in the teratogenic effects 
of alcohol [15, 19, 20]. Recently, a link between oxidative 
stress and the enzymes regulating chromatin structure 
has been identified [21]. These observations would sug-
gest that some of the epigenetic changes induced by alco-
hol may be linked to alterations in the activities of genes 
responding to ROS [15, 20]. However, no study has yet 
directly examined interactions between alcohol expo-
sures, oxidative stress and chromatin structure.
To date, the large majority of studies examining epige-
netic changes arising from fetal alcohol exposures have 
employed either chronic models of constant exposure 
or examinations of acute alterations in chromatin struc-
ture [5–7, 10–12, 22–30]. Very few of these studies have 
sought to investigate the lasting heritability of EtOH-
induced changes in chromatin structure arising from an 
acute encounter through development. This is significant 
as while there is ample evidence that chromatin structure 
can be perturbed by external factors, significant ques-
tions remain as to whether post-translational histone 
modifications are heritable, and can possibly contribute 
to environmentally induced phenotypes [31]. Are EtOH-
induced alterations in histone modifications causal in 
FASD phenotypes, or are they merely transient differ-
ences between chromatin states induced by transcrip-
tional/nucleosome remodeling responses to alcohol?
Using an ex  vivo mouse model for fetal neural stem 
cells, our laboratory has shown dramatic reductions 
in histone 3 lysine 27 trimethylation (H3K27me3) in 
response to acute EtOH exposure, but no correlative 
alterations in the localization of the histone methyl-
transferase EZH2 were observed [10]. Current models 
of epigenetic inheritance suggest that during S-phase, 
chromatin modifying enzymes re-establish the histone 
code on newly assembled unmethylated histones, and 
therefore enzyme complexes, like the Polycomb group, 
represent the true locus-specific epigenetic mark passed 
from one generation to the next [32]. These observa-
tions therefore call into question the heritability of alco-
hol-induced epigenetic alterations, and their capacity to 
contribute to fetal alcohol syndrome (FAS) phenotypes. 
This is especially significant as chromatin modifications 
induced by exposures to other drugs of abuse tend to be 
transient, and revert back to control states within hours 
or days after the toxicant is removed [33].
In this study, we sought to examine two major ques-
tions: (1) are the epigenetic modifications induced by 
alcohol associated with a mobilization of epigenetic 
modifying genes downstream of the oxidative stress 
pathways, and (2) do alcohol-induced changes in chro-
matin structure persist beyond the window of exposure? 
We report multiple post-translational histone modifi-
cations display unique, dose-dependent responses to 
EtOH exposure, and in many cases, the epigenetic sig-
natures arising after an acute exposure differ from those 
observed after a recovery period. These changes in chro-
matin structure are associated with persistent alterations 
in transcripts encoding Dnmt1, Ehmt2 (G9a), Eed, Ezh2, 
Kdm1a, Kdm4c, Setdb1, Sod3, Tet1 and Uhrf1. Tran-
sitioning into an in  vivo model, we observe that mice 
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displaying craniofacial malformations and midline brain 
defects arising from an acute, early gestational exposure 
also display epigenetic errors, and that these signatures of 
change are consistent with those modeled in vitro after a 
recovery period. Our results indicate that the immediate 
and long-term impacts of EtOH exposure on chromatin 
structure are distinct and suggest the existence of a coor-
dinated cellular response to exposure. Importantly, an 
epigenetic signature resulting from an acute gestational 
encounter persists beyond the window of exposure, and 
strongly correlates with the appearance of congenital 
malformations.
Results
Acute and post‑recovery epigenetic signatures of EtOH 
exposure display distinct, dose‑dependent profiles
We sought to model the capacity of primary fetal cer-
ebral cortical neuroepithelial stem cells to restore alco-
hol-induced alterations in chromatin structure. To this 
end, we initiated a treatment protocol wherein cells were 
maintained in the stem cell state and exposed to vary-
ing concentrations of EtOH for 3  days; then allowed to 
progress through a 4-day recovery period representing at 
least three population doublings. The concentrations of 
alcohol utilized in this study were meant to mimic those 
obtained from a binge drinker. We utilized projected 
concentrations based on observations by White et  al., 
which demonstrated that out of 7356 college age females 
surveyed, 33.7  % reported typical consumption rates at 
1×  binge alcohol levels (four or more drinks at a time) 
and 8.2 % reported consumption at 2× binge levels (eight 
or more drinks at a time) [34]. Based on average height 
and weight, these rates of consumption would yield blood 
alcohol levels in the range of 160 and 240 mg/dL, respec-
tively (blood alcohol content—http://www.dot.wisconsin.
gov).
To measure the impact of EtOH exposure and with-
drawal on chromatin structure, control and alcohol-
treated cellular extracts were immunoprecipitated with 
antibodies recognizing the specific chromatin modifica-
tions trimethylated histone 3 lysine 4 (H3K4 me3), tri-
methylated histone 3 lysine 27 (H3K27 me3), acetylated 
histone 3 lysine 9 (H3K9 ac) and dimethylated histone 3 
lysine 9 (H3K9 me2) using methods previously utilized 
by our laboratory [35]. Alterations of these histone post-
translational modifications have been observed in previ-
ous studies of acute alcohol exposure, but their capacity 
to restore over time has not been investigated [10–14]. 
To examine gene-specific alcohol-induced changes in 
chromatin structure, DNA fragments isolated from these 
precipitations were examined by qPCR relative to 1 % of 
the total input. Using primers homologous to sequences 
±250 base pairs of the transcriptional start sites, we 
assessed alterations in chromatin structure occurring 
within the regulatory regions of 22 genes randomly dis-
tributed across the genome that are involved in control-
ling multiple growth factor signaling pathways directing 
neuronal patterning. Importantly, we and others have 
identified altered transcriptional control and aberrant 
localization of transcripts encoding many of these genes 
in FASD mouse models, thus making them suitable can-
didates for the current study [36–39].
The comprehensive results of these independent analy-
ses are presented as a heat map in Fig.  1, with the sta-
tistical significance demarcated in each cell. Analysis 
of individual candidate genes may be viewed in Addi-
tional file  1. For the post-translational marks examined, 
we observed a range of alterations on the order of 45 % 
reductions to more than 200 % increases. These scales of 
change are similar to those reported in experiments uti-
lizing either over-expression or RNA interference medi-
ated suppression of key epigenetic modifiers [EHMT1/
G9a and Polycomb Repressive Complex 2 (PRC2)] 
[40–43]. Collectively, these experiments produced five 
novel observations. First, the examined histone post-
translational modifications were not equally impacted 
by alcohol exposure. Broadly, the candidate genes exam-
ined displayed modest alterations in H3K4 me3, more 
pronounced changes in H3K27 me3 and H3K9 ac, and 
profound shifts in H3K9 me2 across all treatment groups 
and time points examined. It is interesting to note that 
epigenetic modifications associated with a condensed 
chromatin architecture displayed the largest and most 
frequent changes.
Second, we observed that a loss of histone marks 
associated with repressive chromatin structure did not 
immediately correlate with gains in post-translational 
modifications associated with relaxed chromatin struc-
ture, and similarly, loci displaying decreases in marks 
associated with transcription did not see increases in 
post-translational modifications associated with gene 
repression. A number of studies have suggested an inter-
dependent relationship between many of the marks 
examined here, yet even after a recovery period, this lack 
of correlation persists. Third, a clear dose-dependent 
effect exists between the epigenetic changes observed 
in the 160 mg/dL and the 240 mg/dL treatment groups. 
While the 160 mg/dL treatment elicited an enrichment of 
H3K4 me3, H3K9 ac, and H3K27 me3, depletion of these 
histone marks were observed in the 240 mg/dL treatment 
groups. Only H3K9 me2 exhibited a uniform depletion 
across treatments at this time point.
Fourth, when extracts obtained after a 4-day recovery 
were examined (Day-7), we noticed a persisting signature 
of exposure that was unique to each post-translational 
modification examined. For example, gene promoters 
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displaying alterations in chromatin modifications asso-
ciated with relaxed chromatin (H3K9 ac and to a lesser 
extent H3K4 me3) on Day-3, maintained the observed 
altered profiles on Day-7. In contrast, loci that had 
become depleted for marks associated with compacted 
chromatin (H3K27 me3, and H3K9 me2) on Day-3 dis-
played a hypermethylated state on Day-7, suggesting 
these genes had been remodeled into a repressive chro-
matin state. The exception being the H3K27 me3 in the 
160  mg/dL treatments, which were hypermethylated on 
Day-3 and became depleted on Day-7. In addition, we 
observed that many genes displaying chromatin profiles 
identical to the control on Day-3 exhibited altered pro-
files on Day-7 and several alterations present on Day-3 
resolved at the Day-7 time point. As examples, the regu-
latory regions of Dlx5 and Nkx2.2 displayed H3K9 me2 
and H3K27 me3 profiles identical to the control on Day-
3, but became hypermethylated by Day-7. Finally, not all 
genes were uniformly affected in our system, and many 
only displayed alterations in a subset of the post-transla-
tional modifications examined. The regulatory region of 
Pax6 for instance only exhibited changes in H3K9ac at 
the Day-7 time point, while all other chromatin marks 
were identical to the controls, at the time points exam-
ined. In contrast, Ascl1, Msx2, Nkx2.2 and Tbx2 all 
displayed significant changes in at least three of the four 
histone marks examined, and these changes varied across 
the range of concentrations tested and time points exam-
ined. Collectively, these results suggest that the epige-
netic changes arising as a consequence of EtOH exposure 
are heavily dependent on the gene under investigation, 
the dose of alcohol encountered, the epigenetic mark 
under investigation, and that the profile of change arising 
acutely is not always consistent with ones measured after 
removal of the toxicant. These observations may have 
relevance to understanding the molecular basis underly-
ing the enormous variation observed in clinical cases of 
FASDs.
EtOH exposure in vitro is associated with alterations 
in transcripts encoding Sod3 and Tet1, but no alterations 
in markers of cell death, oxidative stress, nor significant 
disruption of the oxidative stress transcriptional response
Given the observed increases in ROS following alcohol 
exposure, researchers have speculated that some of the 
teratogenicity associated with EtOH exposure is linked 
to oxidative stress [15, 44]. Recently, a link between com-
ponents of the oxidative stress pathways and enzymes 
controlling chromatin structure has been identified [21, 
45]. To examine a potential link between mobilization of 
Fig. 1 Dose-dependent epigenetic signatures of EtOH exposure persist past the period of exposure. a Experimental paradigm. b Alcohol-induced 
epigenetic alterations in H3K4 me3, H3K9 ac, H3K9 me2, and H3K27 me3. Primary fetal cerebral cortical neuroepithelial stem cells were cultured in 
the presence of 160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in medium lacking EtOH. Samples were collected at days 3 and 7, 
and examined for changes in the indicated post-translational histone modifications using chromatin immunoprecipitation followed by quantitative 
PCR (ChIP-qPCR). Heat maps represent fold change in H3K4 me3, H3K9 ac, H3K9 me2, and H3K27 me3 within the regulatory regions of the genes 
listed. Primers were designed to fall within 250 base pairs of the transcriptional start site. Within the three separate biological replicates (N = 3), 
three ChIPs were performed, and two qPCR replicates performed on each independent ChIP. Statistical measures were conducted using the Wil-
coxon signed rank nonparametric test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
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the oxidative stress response, and the observed altera-
tions in chromatin structure, we began by quantifying 
the transcript levels of 23 well characterized candidate 
genes involved in either the metabolic processing of 
alcohol or the oxidative stress response pathway [44]. Of 
these 23 candidates, transcripts encoding Cyp2e1, Gpx2 
and Gsta2 could not be detected in RNA samples iso-
lated from our neurosphere cultures. Surprisingly, of the 
remaining 20 candidates, the majority of genes exhibited 
a down-regulation at the Day-3 time point and no signifi-
cant alterations at Day-7 (Fig. 2a). The two notable excep-
tions to this trend were Sod3, and Tet1, which measured a 
1.7-fold increase over the control at the Day-7 time point.
We next measured physiological parameters associ-
ated with apoptosis, oxidative stress and cytotoxicity. 
Neurosphere cultures were treated with 80, 160, and 
240  mg/dL EtOH for 72  h, and subsequently examined 
using Annexin 5 and TUNEL assays (Fig.  2b, c). Nei-
ther of these tests indicated a significant increase in 
levels of cellular apoptosis. When we examined our treat-
ment groups for alterations in the levels of glutathione 
(GSH), decreases of which are associated with oxidative 
stress, no significant changes were observed (Fig.  2d). 
We next examined cell cultures for increased levels of 
lactate dehydrogenase (LDH), a marker of generic cell 
stress. Again, this parameter did not show any signifi-
cant changes across the range of EtOH concentrations 
examined (Fig.  2e). These observations suggest that the 
oxidative stress pathways are not broadly engaged in our 
in vitro model of fetal alcohol exposure; at least not at the 
concentrations examined.
EtOH exposure in vitro is not associated with an inhibition 
of histone methyltransferase enzymatic activity but does 
induce alterations in transcriptional regulation
Work by our group has demonstrated reductions in 
H3K27me3 arising due to acute EtOH exposure [10]. We 
therefore sought to determine if the acute losses of H3K9 
me2 and H3K27 me3 observed in our cell culture model 
could possibly be linked to alcohol-induced inhibition of 
histone methyltransferase enzyme activity. To this end, 
cell cultures were treated with an EtOH dose response 
range from 80 to 240 mg/dL, and both H3K9 and H3K27 
methyltransferase activity quantified using a colorimetric 
assay. Neither significant differences in H3K9 nor H3K27 
methyltransferase activity were observed across the range 
of concentrations tested (Fig. 3a, b).
We then examined levels of transcripts encoding ten 
major proteins responsible for regulating DNA meth-
ylation as well as H3K9 and H3K27 methylation (Fig. 3c) 
[46–55]. Interestingly, transcripts encoding Ehmt2 (G9a) 
and Setdb1, the two enzymes responsible for methylat-
ing H3K9, display alcohol-induced suppression on Day-3 
and an up-regulation on Day-7; which is consistent 
with the observations in Fig.  1. However, on Day-3, we 
also observed decreases in the abundance of transcripts 
encoding Kdm1a, and Kdm4c, as well as a modest 
increase in Kdm1a on Day-7. These two enzymes have 
established roles in demethylating H3K9 [54, 55]. None 
of the other factors examined display altered transcript 
profiles on Day-3, with the exception of Uhrf1 in the 
240  mg/dL treatments. In contrast, Dnmt1, Uhrf1, Eed, 
and Ezh2 all exhibited alterations on Day-7. These obser-
vations suggest some of the alterations in chromatin 
structure may be tied to changes in the levels of enzymes 
regulating DNA/histone methylation.
EtOH‑induced alterations in Dnmt1, Tet1 and Uhrf1 
transcript levels are associated with measurable alterations 
in DNA methylation but not DNA hydroxymethylation
Recently, it has been shown that the TET family of Fe(II) 
and α-KG-dependent dioxygenases rely upon oxygen 
to convert 5-methyl-cytosine (5mC) into 5-hydroxy-
methyl-cytosine (5hmC) [56]. This modified form of 
cytosine is abundant in the brain and is hypothesized to 
play a key role in the epigenetic control of neuronal func-
tion [57]. Importantly, the formation of 5hmC can lead to 
demethylation of DNA, which in turn can influence other 
aspects of chromatin structure; including H3K4 me3, 
H3K9 me2, and H3K27 me3 [58–60]. Since our transcript 
profiles, as well as previous studies in other models [8, 
61] have identified alterations in gene family members 
regulating both 5mC and 5hmC, we set out to deter-
mine these alterations were associated with gene-specific 
changes in DNA methylation/hydroxy methylation. To 
this end, we utilized glucosylation of genomic DNA fol-
lowed by methylation-sensitive qPCR (glucMS-qPCR) to 
examine alcohol-induced alterations in eight candidate 
genes. These candidates were identified in previous stud-
ies of 5hmC within the brain and embryonic stem cell-
derived neural progenitor cells [62–64].
To first validate our methodologies, we examined lev-
els of 5mC within the differentially methylated regions 
of two imprinted genes (Peg3 and Snrpn) [65]. Both can-
didates demonstrated 50  % 5mC consistent with one 
allele being methylated and the other unmodified; but no 
detectable 5hmC (Fig. 4a). At these two loci, no signifi-
cant alterations in 5mC were induced by alcohol expo-
sure across the range of concentrations tested and time 
points examined. We then evaluated expression of Snrpn 
in EtOH-exposed cultures and did not observe any sig-
nificant changes, consistent with the stable measures of 
5mC at this locus (Fig. 4b). We next assayed alterations 
in both 5mC and 5hmC within either the gene bodies 
or regulatory regions of eight candidate genes identified 
in previous studies of 5hmC. We observed increases in 
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Fig. 2 EtOH exposure in vitro alters levels of transcripts encoding Sod3 and Tet1, but does not impact measures of cell death or oxidative stress. a 
Measurements of transcripts encoding proteins involved in the metabolic processing of alcohol and oxidative stress response pathways. Primary 
neuroepithelial stem cells were cultured in the presence of 160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in media lacking EtOH. 
Samples were harvested at days-3 and 7, and transcript levels determined by RT-qPCR. Graphs represent three independent biological replicates 
(N = 3), with two independent RT reactions and three independent qPCR measurements for each RT. Significance was measured using a one-way 
ANOVA, error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. b–e Measures of cellular stress and apoptosis in primary neu-
roepithelial stem cells exposed to alcohol. Cells were cultured in the presence of 80–240 mg/dL EtOH for 3 days, then assayed for markers of b and 
c apoptosis, d oxidative stress and e cellular stress. Differences were measured using a one-way ANOVA, error bars represent SEM. Graphs represent 
three separate biological replicates (N = 3)
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Fig. 3 In vitro EtOH exposure does not inhibit methyltransferase enzymatic activity, but does induce alterations in the transcriptional control of 
DNA and Histone methyltransferase enzymes. a, b Measures of histone methyltransferase activity in EtOH-exposed neuroepithelial stem cells. 
Cells were cultured in the presence of 80–240 mg/dL EtOH for 3 days, and cellular extracts assayed for a H3K27 and b H3K9 histone methyltrans-
ferase activity using a colorimetric assay. Differences were measured using a one-way ANOVA. Error bars represent SEM. N = 3. c Measurement of 
transcripts encoding enzymes governing DNA, H3K9, and H3K27 methylation. Primary neuroepithelial stem cells were cultured in the presence 
of 160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in media lacking EtOH. Samples were harvested at days-3 and 7, and transcript 
levels determined by RT-qPCR. Graphs represent three independent biological replicates (N = 3), with two independent RT reactions and three 
qPCR measurements for each RT. Significance was measured using a one-way ANOVA, error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001; 
****p < 0.0001
Page 8 of 19Veazey et al. Epigenetics & Chromatin  (2015) 8:39 
5mC within the 5′UTR of Gf and the regulatory region 
of Sycp3 (Fig. 4c). While we were able to detect very low 
levels of 5hmC consistent with previous reports [62–64], 
none of these loci exhibited alcohol-induced changes as 
compared to the controls (Fig.  4d). In our primary cul-
tures, the 5′UTR of Gf did not exhibit any detectable 
5hmc. Collectively, these results suggest that while the 
observed increase in DNA methyltransferase levels are 
Fig. 4 Alterations in DNA methylation but not hydroxymethylation in EtOH-exposed primary neuroepithelial stem cell cultures. a Stable levels of 
DNA methylation within the differentially methylated regions of the imprinted genes Snrpn and Peg3. Stem cells were cultured in the presence of 
160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in media lacking EtOH. Genomic DNA was collected at days-3 and 7, and analyzed 
for alterations in DNA 5mC and 5hmC using glucMS-qPCR. Graphs represent three independent biological replicates (N = 3), with three qPCR 
measurements each. b Quantification of Snrpn transcript levels using RT-qPCR. Graphs represent three independent replicates (N = 3), with two 
independent RT reactions and three qPCR measurements for each RT. Differences were measured using a one-way ANOVA, error bars represent 
SEM. c, d Measurement of 5mC and 5hmC within the regulatory regions of eight genes identified in previous studies of DNA hydroxymethylation. 
Cells were cultured in the presence of 160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in media lacking EtOH. Genomic DNA was 
collected at days-3 and 7, and analyzed for alterations in DNA c 5mC and d 5hmC using glucMS-qPCR. Differences were measured using a one-way 
ANOVA, error bars represent SEM. Graphs represent three independent biological replicates (N = 3), with three qPCR measurements each
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correlated with modest increases in 5mC, increased Tet1 
transcript levels are not associated with any measurable 
changes in 5hmC across the candidate loci examined.
Alterations in Homeobox gene transcription predominantly 
manifest beyond the window of EtOH exposure
Published reports examining acute EtOH exposure 
have been unable to demonstrate consistent correla-
tions between alterations in H3K4 me3; a histone mark 
enriched at the promoter regions of actively transcribed 
genes [66], and changes in transcription [10, 67, 68]. 
We were therefore curious to determine if the candi-
date genes demonstrating changes in any of the meas-
ured chromatin marks either before or after the recovery 
period would display alterations in gene transcription. 
To this end, RNA was isolated from all treatment groups 
and gene expression measured using quantitative reverse 
transcriptase polymerase chain reaction (qRT-PCR). 
Of the 22 candidate genes examined in Fig.  1, tran-
scripts encoding Ascl1, Dlx2, Dlx3, Pax6, Nkx2.2, Sox1, 
Sox2, Sox17, and Tbx2 could be detected in our cultures 
(Fig. 5). Similar to our previous studies [10], only a very 
small number (20 %) of candidate genes (Ascl1 and Sox2) 
displayed altered expression profiles arising as a con-
sequence of EtOH exposure at Day-3. In contrast, eight 
of the nine detected candidates (~88  %) displayed sig-
nificant alterations in transcript levels on Day-7, across 
both concentrations of EtOH tested. These candidate 
homeobox genes sit at the hub of multiple transcriptional 
pathways controlling cellular identity and prolifera-
tion. We therefore assayed RNA samples for alterations 
in the expression of known markers of both cellular 
growth (Ki67, cMyc, and Rb1) and neural stem cell pro-
liferation/identity (Fabp7, Gfap, Gli3, Nestin, Olig2 and 
Tuj1). These analyses revealed changes in a small num-
ber of candidates within the 240  mg/dL treatments on 
Day-3 (Ki67, Fabp7, and Tuj1), while the larger impact 
was again observed on Day-7, with eight of the nine 
candidates demonstrating alterations in transcription 
(Fig. 6). These observations indicate the larger impact of 
EtOH exposure on the developmental program may arise 
beyond the initial period of exposure.
An epigenetic signature of EtOH exposure arising from an 
acute gestational encounter persists beyond the window 
of exposure
Abnormalities in the cortex of the brain are often associ-
ated with alcohol-induced impairments in high-level sen-
sory and motor processing, as well as with some FASD 
cognitive-behavioral phenotypes. As our stem cell cul-
tures are derived from mouse cerebral cortex precursors, 
we sought to assess the relevance of our in  vitro obser-
vations on the development of FASD-associated birth 
Fig. 5 Distinct alterations in homeobox gene transcription arising 
during and after the window of EtOH exposure. Neural stem cells 
were cultured in the presence of 160 or 240 mg/dL EtOH for 3 days, 
followed by a 4-day recovery in media lacking EtOH. Cells were har-
vested at days-3 and 7, and transcript levels measured using RT-qPCR. 
Graphs represent three independent replicates (N = 3), with two 
independent RT reactions and three qPCR measurements for each 
RT. Differences were measured using a one-way ANOVA, error bars 
represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
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Fig. 6 Alterations in transcripts encoding proteins regulating neural stem cell identity and proliferation predominantly arise after the window of 
EtOH exposure. Neural stem cells were cultured in the presence of 160 or 240 mg/dL EtOH for 3 days, followed by a 4-day recovery in media lacking 
EtOH. Cells were harvested at days-3 and 7, and transcript levels measured using RT-qPCR. Graphs represent three independent replicates (N = 3), 
with two independent RT reactions and three qPCR measurements for each RT. Differences were measured using a one-way ANOVA, error bars 
represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001
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defects. The C57Bl/6J mouse has been critical in defining 
some of the stage-dependent dysmorphologies resulting 
from acute early gestational ethanol exposures. An acute 
binge-like ethanol treatment on gestational day 7 (GD7) 
(equivalent to the early third week of human develop-
ment—gastrulation) results in a range of grossly observa-
ble fetal anomalies such as holoprosencephaly and classic 
FAS facial characteristics [69, 70]. Importantly, both the 
craniofacial and midline brain anomalies can be consist-
ently scored and their degree of severity correlated with 
concurrently developing defects within the CNS [70, 71]. 
We therefore examined the prevalence of altered chro-
matin structure within the cortex of mouse pups exposed 
to an early, binge-like gestational exposure.
On GD7, pregnant dams were intraperitoneally admin-
istered two injections of either vehicle or 2.9 g/kg EtOH 
4 h apart, yielding peak maternal blood alcohol concen-
trations averaging 440  mg/dL [70]. These blood alcohol 
concentrations are much higher than those utilized in 
our in  vitro studies; however, in mouse models of FAS, 
lower concentrations do not consistently produce holo-
prosencephaly and classic FAS facial characteristics [71]. 
We therefore elected to use a treatment paradigm that 
would produce a low, but consistent frequency of alco-
hol-induced birth defects, yet that was not overtly toxic. 
On GD17, stage-matched control and EtOH-exposed 
fetuses were dissected, and scored for ocular defects as 
described previously [71]. Using this model, 12 % of the 
EtOH-exposed pups displayed holoprosencephaly and 
FAS facial characteristics, whereas the remaining animals 
were morphologically normal. Mice were then sorted 
into groups by treatment and morphological appearance. 
In total, 25 mice from 6 different litters were selected for 
analysis: 10 control, 8 EtOH exposed—morphologically 
normal, and 7 EtOH exposed—malformed. To examine 
the impact of EtOH exposure upon the epigenetic pro-
gram of the developing central nervous system, the fetal 
cortex was dissected out, and using chromatin immuno-
precipitation, we assayed cellular extracts for alterations 
in the chromatin marks examined above (Fig. 7).
In samples derived from EtOH exposed—malformed 
pups, we observed a pattern of change that largely cor-
related with the in vitro post-recovery signature observed 
in the 160  mg/dL treatment group in Fig.  1. Fetal mice 
exhibiting craniofacial dysmorphology and midline brain 
defects displayed loss of H3K27 me3 in 14 of the 24 (58 %) 
candidates examined, a modest enrichment of H3K9 ac 
in 7/24 candidate genes (29 %), and a dramatic increase 
in H3K9 me2 in 17/24 (70 %) of the candidate regulatory 
regions examined. The hypermethylated state of H3K9 
in particular was robust and very consistent. With the 
exception of a modest change within the promoter region 
of Msx2, no alterations of H3K4 me3 were observed in 
the EtOH exposed—malformed tissue samples. It is 
interesting to note that across at least three of the four 
post-translational modifications examined, Dlx2, HoxA6, 
HoxA7, Msx2, and Vdr consistently displayed alterations 
in chromatin structure, suggesting certain genes may 
be more susceptible to epigenetic errors than others. In 
our analysis, we noticed that post-translational modifi-
cations associated with repressive chromatin structure 
are profoundly impacted as compared to those associ-
ated with transcriptionally active, yet these changes move 
in opposite directions; H3K27 me3 is lost while H3K9 
me2 is gained. This was surprising given EHMT2 (G9a) 
and the Polycomb group have been observed as part of a 
common complex, and on at least a subset of genes in ES 
cells, increased H3K9 me2 enhanced EZH2 activity [40]. 
In contrast, EtOH exposed—morphologically normal 
pups displayed modest changes in H3K4 me3 and H3K27 
me3, while levels of H3K9 me2 were identical to those 
measured in the controls. Collectively, these observations 
indicate that an epigenetic signature of EtOH exposure 
persists beyond the window of exposure, and is largely 
linked to alterations in repressive chromatin structure; 
H3K9 me2 in particular. Importantly, these observed 
alterations strongly correlate with the development of 
FASD-associated congenital malformations.
Discussion
Epidemiologic studies have shown that alcohol is the 
most prevalent teratogen to which humans are exposed, 
and in the United States, 6–9 infants per 1000 live births 
are diagnosed with some degree of fetal alcohol spectrum 
disorder [72]. Despite years of intense study, determin-
ing the developmental basis for the enormous variation 
in both the severity and range of birth defects linked to 
prenatal alcohol exposure remains a formidable chal-
lenge. We and others have demonstrated multiple altera-
tions in chromatin structure arising as a consequence of 
EtOH exposure, but linking these epigenetic changes to 
alterations in the developmental program, and ultimately 
to the acquisition of congenital abnormalities, has yet 
to be achieved [2, 3]. Our observation that the two con-
centrations of EtOH tested in  vitro were able to elicit 
distinct changes in chromatin structure suggest some of 
the variation in FAS clinical cases may be attributable to 
dose-dependent alterations in the epigenetic program. It 
is noteworthy that the direction of change arising from 
the 160 mg/dL exposure for H3K4 me3, H3K27 me3, and 
H3K9 ac are opposite to those induced by the 240 mg/dL 
treatments. Only H3K9 me2 was uniformly affected. The 
mechanisms underlying the observed non-linear dose 
responses in fetal alcohol exposure are unclear. However, 
such data emphasize that the teratogenic potential of eth-
anol is not diminished with lower doses.
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Alterations in H3K9 me2 are consistently induced by 
EtOH exposure, persist beyond the window of expo-
sure, and have a strong association with the develop-
ment of congenital abnormalities. Previous studies of 
acute EtOH-induced liver injury, neuroplasticity, neuro-
degeneration, and neuroadaptation have also observed 
gene-specific changes in H3K9 methylation indicating 
alterations to this post-translational mark may be a core 
aspect of EtOH teratogenicity [11, 13, 73, 74]. The cor-
relative shifts in transcript abundance of the major genes 
regulating the dynamics of H3K9 methylation support 
this assertion. Recently, two independent studies in yeast 
have reported a potential reader–writer mechanism of 
epigenetic inheritance for H3K9 methyl-marks [75, 76]. 
These observations suggest disruptions in H3K9 meth-
ylation may be heritable through development, and 
therefore represent a plausible mechanism of transmit-
ting a lasting signature of EtOH exposure. If alterations 
at this residue are indeed linked to gestational EtOH 
exposures causing birth defects, we speculate this signa-
ture may be identifiable in clinical samples such as cord 
blood, and thus potentially serve as a biomarker of expo-
sures linked to patterning defects. If true, this could yield 
the potential to identify FASD cases that do not present 
with overt craniofacial abnormalities, but yet have asso-
ciated neurological deficits [72]. The predictive value of 
epigenomic markers over genetic ones is starting to gain 
wider acceptance [77], thus this strategy may be helpful 
in the delivery of FASD educational interventions at the 
earliest possible points.
Researchers have speculated that some of the tera-
togenicity associated with EtOH exposure is linked to 
oxidative stress, and inhibition of aspects of one carbon 
metabolism [15, 78]. Our data both in vitro and in vivo, 
suggest that some loci gain methylation while others 
exhibit a decrease. Specifically, the dramatic increases 
in H3K9 me3 observed within our candidate gene regu-
latory regions does not support the notion that a short-
age of methyl groups underlies the observed changes in 
chromatin structure. However, our analysis is focused on 
select regulatory sequences and does not examine global 
changes in any of these post-translational histone marks, 
nor does it examine alterations in global levels of DNA 
methylation, which previous reports have found to be 
significantly reduced in EtOH-exposed animals [5, 8]. 
Additionally, we did not observe a correlation between 
epigenetic alterations brought on by in vitro EtOH expo-
sure and changes in the examined markers of cell death, 
cell stress or oxidative stress. Although we did observe 
alterations in Tet1 transcript levels, these were not asso-
ciated with measurable changes in 5hmC. Thus, we were 
unable to find evidence supporting the notion that epi-
genetic modifications induced by alcohol are associated 
with genes downstream of the oxidative stress pathways, 
at least at the concentrations examined here.
Current research suggests epigenetic changes to the 
chromatin template begin at conception and continue 
as an iterative process enabling a progressive “memory” 
of prior developmental fate decisions. However, the bio-
chemical nature of this memory is the subject of some 
debate. In the case of the H3K27 me3 mark, work by two 
independent laboratories has suggested that established 
H3K27 me3 attracts the EED component of the Poly-
comb Repressive Complex 2 (PRC2), and is required to 
stimulate the enzymatic activity necessary to maintain 
this mark on the daughter strands during incorpora-
tion of newly synthesized histones [79, 80]. In contrast, 
another study has suggested that only binding of the 
Polycomb complex through S-phase is required to propa-
gate this post-translational modification [32]. We have 
previously observed depletion of H3K27 me3 at multiple 
loci in response to EtOH exposure; however, ChIP analy-
sis of EZH2 binding failed to identify significant changes 
in PRC2 localization [10]. The persisting reductions of 
this mark observed 10 days after an acute in vivo expo-
sure, but not within in vitro neurosphere cultures main-
tained in the stem cell state, suggest recovery of this mark 
may be dependent upon cells being in a stem cell versus a 
differentiating state.
In our in  vitro studies, we did not observe a consist-
ent correlation between alcohol-induced alterations in 
histone post-translational modifications and changes in 
gene transcription. The large majority of alterations in 
chromatin structure we observed indicate an increase in 
(See figure on preivous page.) 
Fig. 7 Lasting alcohol-induced alterations in H3K4 me3, H3K9 ac, H3K9 me2, and H3K27 me3 within the prenatal cortex arising from an early 
gestational exposure. Pregnant dams were injected with 2.9 g/kg EtOH at GD7 and embryos harvested at GD17. Embryos were scored for ocular 
and cortical patterning defects, and sorted into three groups—control, EtOH exposed—morphologically normal, and EtOH exposed—malformed. 
After dissection of the fetal cortex, ChIP-qPCR analysis was performed on cellular extracts using antibodies recognizing H3K4 me3, H3K9 ac, H3K9 
me2, and H3K27me3. a, c Heat maps representing fold change in the levels of the indicated post-translational modifications relative to samples 
derived from saline-exposed controls. In the experiments examining H3K4 me3 and H3K27 me3, four ChIP experiments were performed on a total 
of 15 brains across 5 different litters. For analysis of H3K9 ac and H3K9 me2, three ChIP experiments were performed on a total of 10 brains across 
5 different litters. Two replicates of qPCR were performed on each ChIP. Significance was determined using a two-way ANOVA. Error bars represent 
SEM.*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. b, d Representative graphs depicting alcohol-induced alterations in chromatin structure. A 
complete analysis of individual genes may be viewed in Additional file 2
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marks associated with transcriptional repression at Day-
7, yet our candidate genes demonstrated an increase in 
expression at this time. These in  vitro observations add 
one more piece of data to suggest histone post-transla-
tional modifications, in isolation, are not likely causal in 
regulating transcription [31]. Therefore, the established 
lexicon of ‘activating’ and ‘repressive’ chromatin modifi-
cations is an over-simplification that should be curtailed. 
Basic principles of teratogenesis state that a teratogen 
must cause malformations through a specific mecha-
nism during a period in which the conceptus is suscep-
tible to said mechanism [81]. Embryonic stem cells have 
been derived with genetic deletions of the major enzymes 
controlling DNA methylation (Dnmt1−/−Dnmt3a−/−
Dnmt3b−/−triple knockout), H3K27 me3 (Suz12−/−) 
and H3K9 me2/me3 [(G9a−/−GLP−/− double knock-
out) (Suv39h1−/−/Suv39h2−/−double knockout) ESET/
Setdb1 knockout−/−] [82–86]. In most cases, these cells 
continue to grow and demonstrate subtle changes in gene 
transcription. However, once induced to begin the pro-
cess of differentiation, these cultures uniformly undergo 
apoptosis. Thus, perhaps the stem cell state is tolerant of 
major shifts in chromatin structure without associated 
perturbation of transcriptional control, while in contrast, 
differentiating cells become ‘locked in’ and are more reli-
ant upon chromatin states to control gene expression. 
In animal models, correlation of acute EtOH exposures 
with major periods of organ growth indicate that dif-
ferent tissues are largely susceptible to alcohol-induced 
teratogenesis during specific developmental windows. It 
is thus tempting to speculate that differences in chroma-
tin biology between pluripotent, differentiating and dif-
ferentiated cells underlie some aspects of susceptibility to 
alcohol teratogenesis.
Our analysis of mouse cortices derived from EtOH-
exposed, malformed pups clearly indicate alterations in 
chromatin structure are heritable and persist beyond the 
window of exposure. Importantly, these alcohol-induced 
changes in chromatin structure can be found within the 
regulatory regions of genes with clear links to the devel-
opment of FASD clinical phenotypes (Fig. 7b, d) [36, 38]. 
Thus, our data strongly suggest acute alcohol exposures 
have the capacity to perturb the developmental pro-
gram and contribute to EtOH-induced birth defects. As 
approximately 50  % of pregnancies in the United States 
are unplanned, many women inadvertently subject 
their children to acute prenatal EtOH exposures [87]. 
Therefore, a better understanding of the role of alcohol-
induced epigenetic errors in the development program 
play in the etiology of FASDs will enhance our ability to 
develop clinical interventions and better diagnostics in 
the treatment of this condition.
Methods
Neural stem cell culture and EtOH exposure
All animal procedures were approved and conducted in 
accordance with the Institutional Animal Care and Use 
Committee at the Texas A&M College of Veterinary 
Medicine (protocol number 2014-0087), and the Uni-
versity of North Carolina. Derivation of primary mouse 
fetal cerebral cortical neuroepithelial stem cells have 
been described in detail previously [88]. Cells were cul-
tured as free floating neurospheres in T75 flasks con-
taining a 50/50  % mixture of Neurobasal media (Cat# 
21103-049; Invitrogen) and DMEM F-12 (Cat# 11320-
033; Invitrogen). This medium was supplemented with 
the N2-supplement (Cat# 17502-048; Invitrogen), B27 
supplement (Cat# 17504-044; Invitrogen), 0.05  % TC 
grade BSA in PBS (Cat# A1933 Sigma), 2  mM  l-glu-
tamine (Cat# 25030-081; Invitrogen), 1× penicillin/
streptomycin (Cat# 15140-122; Invitrogen), 20  µg/mL 
FGF basic (Cat# PMG0034; Invitrogen), 20 µg/mL EGF 
(Cat# PHG0311; Invitrogen), and 0.85 units/mL heparin 
(Cat# H3149; Sigma). Neurospheres were incubated at 
37  °C, in a 5  % CO2 humidified environment. Medium 
was changed every 2 or 3 days depending on the level of 
confluence. Alcohol treatment groups were cultured in 
medium containing either 80, 120, 160, 240  mg/dL, or 
control cultures containing no EtOH. Cells were grown 
in flasks sealed with parafilm to prevent evaporation. 
Medium treatments were replaced every 48 h and sam-
ples collected for ChIP and RNA analysis at the indi-
cated time points.
Chromatin immunoprecipitation analysis
Cells were grown to 80  % confluence, washed twice in 
warm PBS, dissociated using Accutase (Cat# SCR005; 
Millipore), and resuspended in warm medium (DMEM 
F-12 Cat# 11320-033; Invitrogen) containing 0.1 vol-
ume crosslinking solution [89]. ChIP reactions were 
performed as described previously [35] followed by 
DNA purification using a Qiaquick PCR Cleanup kit 
(Cat# 28106; QIAGEN). Antibodies used include: anti-
H3K4me3 (Cat# 04-745; Millipore), anti-H3K27me3 
(Cat# 39155; Active Motif ), anti-H3K9ac (Cat# 07-352; 
Millipore), and anti-H3K9me2 (Cat# 39239; Active 
Motif ). Antibodies for modified histones were used at 
1  µg/ChIP reaction. The concentration of IgG (Cat# 
SC-2027; Santa Cruz) was also used at 1  µg/ChIP. For 
analysis of candidate loci, real-time PCR was performed 
using the Dynamo Flash supermix (Cat# F-415XL; 
Thermo Scientific) according to the recommended pro-
tocol. Reactions were performed on a Bio-Rad CFX384 
Touch PCR system. Primer sequences are listed in Addi-
tional file 3.
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Murine fetal forebrain chromatin immunoprecipitation 
analysis
IP injections of EtOH (2.9  g/kg) were administered to 
pregnant dams at GD7 as described previously [70]. 
Control dams were injected with a comparable volume 
of lactated Ringer’s solution. Embryos were harvested at 
GD17, and fetal mice scored for ocular and cortical pat-
terning defects [70, 71]. After assessment, the left and 
right cortices were dissected and flash frozen. Cortices 
of a single brain were thawed and filtered into a single-
cell suspension using gentle mechanical dissociation in 
a 100  μm cell strainer (Cat# 352360; Corning Life Sci-
ences). Cells were washed twice with PBS containing pro-
tease inhibitor cocktail (Cat# 78437; Thermo Scientific) 
and resuspended in medium (DMEM F-12 Cat# 11320-
033; Invitrogen) containing 0.1 volume crosslinking solu-
tion [89]. ChIP reactions were performed as described 
above.
RNA analysis
Cultured cells were grown to 80  % confluence, washed 
twice in warm PBS, and dissociated with 1× trypsin 
(Accutase Cat# SCR005; Millipore). Cells were spun 
down, washed once in cold PBS, and RNA isolated using 
Trizol (Cat# 15596026; Invitrogen) according to the man-
ufacturer’s protocol. One microgram of purified total 
RNA was treated with amplification grade DNase I (Cat# 
AMPD1; Sigma) according to the manufacturer’s recom-
mendations, and 250 ng RNA seeded into a reverse tran-
scription reaction using the SuperScriptII system (Cat# 
18064-071; Invitrogen) by combining 1 µL random hex-
amer oligonucleotides (Cat# 48190011; Invitrogen), 1 µL 
10  mM dNTP (Cat# 18427-013; Invitrogen), and 11  µL 
RNA plus water. This mixture was brought to 70  °C for 
5  min and then cooled to room temperature. Super-
ScriptII reaction buffer, DTT, and SuperScriptII were 
then added according to manufacturer’s protocol, and 
the mixture brought to 25 °C for 5 min, 42 °C for 50 min, 
45  °C for 20  min, 50  °C for 15  min, and then 70  °C for 
5 min. Relative levels of candidate gene transcripts were 
analyzed using the Dynamo Flash mastermix according 
to the recommended protocol. Reactions were performed 
on a Bio-Rad CFX38. Primer sequences are listed in 
Additional file 3.
Histone methyltransferase activity assay
Cells were dissociated, washed twice in PBS, pelleted, and 
nuclear extracts prepared. Briefly, cell pellets were ini-
tially resuspended in 200 µL of Buffer A (10 mM HEPES, 
10 mM KCl, 0.1 mM EDTA). Following a 10-min incuba-
tion, samples were centrifuged at 20,000×g for 3 min at 
4  °C. The supernatants were removed and nuclei resus-
pended in 30 µL Buffer B (20 mM HEPES, 0.4 M NaCl, 
1  mM EDTA, 10  % glycerol). Samples were shaken at 
1000 RPM for 2 h followed by centrifugation at 20,000×g 
for 5  min. H3K9 and H3K27 Methyltransferase activity 
were assayed using the EpiQuik HMT Activity Assay Kit 
(Cat# P-3005, P3003; Epigentek), according to the manu-
facturer’s instructions. Absorbance was measured on a 
Cary Eclipse microplate reader (Agilent Technologies) at 
a wavelength of 450 nm. Activity was calculated accord-
ing to the manufacturer’s instructions.
Analysis of cellular stress and apoptosis
Intracellular glutathione assay
One million cells were prepared in 1  mL warm DMEM 
F-12 (Cat# 11320-033; Invitrogen), and glutathione 
measured using an Intracellular GSH detection assay 
(Cat# ab112132; Abcam) following the manufacturer’s 
recommendations. Fluorescence was monitored using an 
Accuri C6 flow cytometer (BD Biosciences).
Lactate dehydrogenase assay
One million cells were collected and LDH levels quanti-
fied using a Lactate Dehydrogenase Activity Assay Kit 
(Cat# MAK066; Sigma), according to the recommended 
protocol. Measurements were taken using a Cary Eclipse 
microplate reader (Agilent Technologies) at a wavelength 
of 450 nm.
Annexin V apoptosis assay
Cells were examined using the Annexin V Apoptosis 
Detection Kit (APC; Cat# 88-8007; eBioscience). Five 
million cells were washed once in PBS and resuspended 
in binding buffer. 5 µL of Annexin V was added to 100 µL 
of cell suspension and incubated for 15  min at room 
temperature. Cells were then washed in PBS and resus-
pended in 200  µL of Binding Buffer. 5  µL of propidium 
iodide solution was added, and cells analyzed using an 
Accuri C6 flow cytometer (BD Biosciences).
TUNEL assay
Using a APO-BrdU TUNEL Assay Kit (Cat# A35127; Inv-
itrogen), one million cells were fixed using paraformal-
dehyde and resuspended in 50 µL DNA labeling solution 
according to the manufacturer’s protocols. 500 µL of pro-
pidium iodide/RNase A staining buffer was added to each 
sample and incubated for an additional 30 min at room 
temperature in the dark. Samples were analyzed using an 
Accuri C6 flow cytometer (BD Biosciences).
Analysis of DNA methylation and DNA hydroxymethylation
Genomic DNA was isolated from treated neurospheres 
using the DNeasy Blood and Tissue kit (Cat# 69506; 
QIAGEN) according to the recommended protocol. 
We utilized glucosylation of genomic DNA followed by 
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methylation-sensitive qPCR (glucMS-qPCR) to quan-
tify levels of 5-methyl-cytosine and 5-hydroxy-methyl-
cytosine. Here, 30 µg of genomic DNA was treated with 
30 units of T4 phage β-glucosyltransferase (T4 BGT, 
Cat# M0357S; NEB) at 37  °C overnight. Glycosylated 
genomic DNA was then digested with 100 units of MspI 
(Cat# R0106M; NEB) or 50 units of HpaII (Cat# R0171L; 
NEB), or no enzyme at 37  °C overnight. Reactions were 
inactivated by treatment with proteinase K (Cat# 19133; 
QIAGEN) at 40 °C for 30 min. The proteinase K was inac-
tivated by incubation at 95 °C for 10 min. The HpaII- or 
MspI-resistant fractions were quantified by qPCR using 
primers designed around a single HpaII/MspI site. Prim-
ers listed in Additional file 3. Levels of 5-methyl-cytosine 
were determined by calculating differences in HpaII- vs. 
MspI-digested samples using the following formula: 
[% methylation  =  (2(Uncut T4BGT treated  −  HpaII cut T4BGT 
treated) −  2(Uncut T4BGT treated −  MspI cut T4BGT treated)) ×  100]. 
Levels of 5-hydroxy-methyl-cytosine were determined 
by calculating the difference between glucosylated sam-
ples and genomic DNA digested with MspI using the fol-
lowing formula: [% hydroxymethylation =  (2(Uncut T4BGT 
treated − MspI cut T4BGT treated) − 2(Uncut − MspI cut)) × 100].
Statistical analysis
For all experiments, statistical significance was set at 
alpha = 0.05.
For analysis of gene expression, the replicate cycle 
threshold (CT) values for each transcript were compiled 
and normalized to the geometric mean of the reference 
genes phosphoglycerate kinase 1 (Pgk1—NM_008828), 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh—
NM_008084), and hypoxanthine-phosphoribosyl trans-
ferase (Hprt—NM_013556). From our previous studies 
of 14 candidate reference genes in EtOH-exposed cul-
tures, Pgk1, Gapdh, and Hprt have been validated as sta-
ble across the range of alcohol treatments utilized in this 
study [90]. Normalized expression levels were calculated 
using the DDCT method described previously [91]. Val-
ues from each biological replicate were transferred into 
the statistical analysis program GraphPad (GraphPad 
Software, Inc., La Jolla, CA, USA), verified for normality, 
and an analysis of variance (ANOVA) run to assay dif-
ferences between experimental treatments. For samples 
with p values <0.05, we applied Tukey’s HSD analysis for 
multiple comparisons, and have marked statistically sig-
nificant differences with an asterisk.
For quantitative analysis of candidate gene regulatory 
region enrichment in primary fetal cerebral cortical neu-
roepithelial stem cells, ChIP samples were first normal-
ized to 1 % input, using the formula previously described 
by Mukhopadhyay et al. [92]. To independently examine 
alterations in each post-translational modification, the 
means from each independent sample were normalized 
to the control. The results of three independent experi-
ments were then tabulated, cumulative means calculated 
and standard error of the mean derived. The statistical 
analysis package GraphPad was used to first measure 
the normality of samples using the D’Agostino–Pearson 
test. As several of the candidate genes did not exhibit a 
normal distribution, we quantified differences between 
control and EtOH-treated samples using the Wilcoxon 
signed rank test. This nonparametric test is applied when 
the population has unequal variances and cannot be 
assumed to be normally distributed. Importantly, this test 
has been widely employed in genome wide studies of his-
tone variants, histone post-translational marks and tran-
scription factor binding [93, 94].
For quantitative analysis of candidate gene regula-
tory region enrichment in fetal forebrains, ChIP samples 
were normalized to 1  % input, using the formula previ-
ously described [92]. The cumulative mean from each of 
the three independent experiments was calculated and 
the standard error of the mean derived. The statistical 
analysis package GraphPad was used to verify normality, 
and assay differences between each of the control, EtOH 
exposed—morphologically normal, and EtOH exposed—
malformed samples using a two-way analysis of variance 
(ANOVA).
For quantitative analysis of DNA methylation, percent-
ages of DNA 5-methylcytosine and 5-hydroxymethyl-
cytosine derived from the formulas listed above were 
transferred into the statistical analysis package Graph-
Pad, verified for normality, and an analysis of variance 
(ANOVA) run to assay differences between experimental 
treatments. A Student’s t test was run to assay differences 
between days 3 and 7 among all samples tested.
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